- We will send in 10–14 business days.
/images/books/13787693/9784158373520.jpg)
- Author: P Rohitkumar
- Publisher: infotech publishers
- ISBN-10: 4158373522
- ISBN-13: 9784158373520
- Format: 15.2 x 22.9 x 1.3 cm, minkšti viršeliai
- Language: English
- SAVE -10% with code: EXTRA
Analysis of financial performance of selected pharmaceutical companies of india (e-book) (used book) | bookbook.eu
Reviews
Description
GLOBAL PHARMACEUTICAL INDUSTRY
The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug
firms control more than one-third of this market, many with annual revenue of more than US$ 10 billion and profit margins of about 30%. Six are based in the sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 22d.20:22:48
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: P Rohitkumar
- Publisher: infotech publishers
- ISBN-10: 4158373522
- ISBN-13: 9784158373520
- Format: 15.2 x 22.9 x 1.3 cm, minkšti viršeliai
- Language: English English
GLOBAL PHARMACEUTICAL INDUSTRY
The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug
firms control more than one-third of this market, many with annual revenue of more than US$ 10 billion and profit margins of about 30%. Six are based in the sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.
Reviews